Join
Live feed
·
PRReleasevia Quantisnow
Lakewood-Amedex Biotherapeutics Inc. logo

Lakewood-Amedex Expands Global IP Portfolio for Lead Candidate, Nu-3, Targeting Infected Diabetic Foot Ulcers

ByQuantisnow·Wall Street's wire, on your screen.
LABT· Lakewood-Amedex Biotherapeutics Inc.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LABT (Lakewood-Amedex Biotherapeutics Inc.) and more on Quantisnow.